Analysts Set Sanofi (NASDAQ:SNY) PT at $51.00

Shares of Sanofi (NASDAQ:SNY) have been assigned a consensus recommendation of “Hold” from the fifteen brokerages that are covering the firm, MarketBeat.com reports. Ten investment analysts have rated the stock with a hold rating, three have assigned a buy rating and two have given a strong buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $51.00.

Several research analysts recently weighed in on SNY shares. Weiss Ratings raised shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 13th. Wall Street Zen downgraded shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Argus raised shares of Sanofi to a “strong-buy” rating in a research note on Monday, April 27th. BNP Paribas Exane downgraded shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price objective for the company. in a research note on Monday, April 20th. Finally, Citigroup reaffirmed a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th.

Sanofi Trading Down 0.3%

Shares of SNY stock opened at $44.15 on Wednesday. The firm has a 50-day moving average price of $45.61 and a 200 day moving average price of $47.14. Sanofi has a twelve month low of $42.33 and a twelve month high of $53.03. The company has a market capitalization of $107.68 billion, a price-to-earnings ratio of 12.33, a PEG ratio of 1.09 and a beta of 0.35. The company has a current ratio of 1.01, a quick ratio of 0.22 and a debt-to-equity ratio of 0.17.

Sanofi Increases Dividend

The firm also recently announced an annual dividend, which will be paid on Wednesday, June 3rd. Investors of record on Monday, May 4th will be given a dividend of $2.4225 per share. This is a boost from Sanofi’s previous annual dividend of $2.04. The ex-dividend date of this dividend is Monday, May 4th. This represents a yield of 559.0%. Sanofi’s dividend payout ratio is currently 49.16%.

Hedge Funds Weigh In On Sanofi

Institutional investors and hedge funds have recently bought and sold shares of the stock. Flagship Harbor Advisors LLC purchased a new position in Sanofi in the 4th quarter worth approximately $25,000. Physician Wealth Advisors Inc. boosted its stake in shares of Sanofi by 180.5% during the 1st quarter. Physician Wealth Advisors Inc. now owns 589 shares of the company’s stock valued at $28,000 after buying an additional 379 shares during the last quarter. Leonteq Securities AG boosted its stake in shares of Sanofi by 95.8% during the 1st quarter. Leonteq Securities AG now owns 607 shares of the company’s stock valued at $29,000 after buying an additional 297 shares during the last quarter. Western Wealth Management LLC purchased a new position in shares of Sanofi during the 1st quarter valued at approximately $29,000. Finally, Measured Wealth Private Client Group LLC purchased a new position in shares of Sanofi during the 3rd quarter valued at approximately $29,000. Hedge funds and other institutional investors own 14.03% of the company’s stock.

Sanofi Company Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.